Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Mar;103(6):773-8.
doi: 10.1172/JCI5624.

MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B

Affiliations

MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B

J Gosling et al. J Clin Invest. 1999 Mar.

Abstract

The earliest recognizable atherosclerotic lesions are fatty streaks composed of lipid-laden macrophages (foam cells). Circulating monocytes are the precursors of these foam cells, but the molecular mechanisms that govern macrophage trafficking through the vessel wall are poorly understood. Monocyte chemoattractant protein-1 (MCP-1), a member of the chemokine (chemotactic cytokine) family, is a potent monocyte agonist that is upregulated by oxidized lipids. Recent studies in hypercholesterolemic mice lacking apo E or the low-density lipoprotein receptor have suggested a role for MCP-1 in monocyte recruitment to early atherosclerotic lesions. To determine if MCP-1 is critically involved in atherogenesis in the setting of elevated physiological plasma cholesterol levels, we deleted the MCP-1 gene in transgenic mice expressing human apo B. Here we report that the absence of MCP-1 provides dramatic protection from macrophage recruitment and atherosclerotic lesion formation in apo B transgenic mice, without altering lipoprotein metabolism. Taken together with the results of earlier studies, these data provide compelling evidence that MCP-1 plays a critical role in the initiation of atherosclerosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Atherosclerotic lesion area in MCP-1+/+HuBTg+/0 and MCP-1–/–HuBTg+/0 mice. Microscopic cross sections (10 μm) of the proximal aortic root were stained with oil red O to reveal lipids and quantitated by digital morphometry. Each symbol represents the average lesion area of a single animal; the bar indicates the mean of the group. At each time, MCP-1+/+HuBTg+/0 mice had a significantly larger mean lesion area than MCP-1–/–HuBTg+/0 mice: 64,606 vs. 25,886 μm2 at 9 weeks (n = 11; P = 0.0083); 185,772 vs. 53,027 μm2 (n ≥ 9; P = 0.0001) at 15 weeks; and 305,790 vs. 123,025 μm2 at 18 weeks (n ≥ 8; P = 0.0009). MCP-1, monocyte chemoattractant protein-1.
Figure 2
Figure 2
Photomicrographs of proximal aortic lesions in MCP-1+/+HuBTg+/0 and MCP-1–/–HuBTg+/0 mice maintained on a high-fat diet for 18 weeks. Sections were taken at the level of the coronary artery and stained for lipid with oil red O. (a) MCP-1+/+HuBTg+/0; (b) MCP-1–/–HuBTg+/0. Shown are representative images from the data presented in Fig. 1. Original magnification ×70.
Figure 3
Figure 3
Photomicrographs showing macrophage infiltration of the proximal aorta in MCP-1+/+HuBTg+/0 and MCP-1–/–HuBTg+/0 mice maintained on the high-fat diet for 15 weeks. Cross-sections of the aorta at the level of the coronary artery branch were stained for macrophages with MOMA-2 (shown in red) and counterstained for nuclei with SYTOX Green. Regions of overlap appear yellow. (a) MCP-1+/+HuBTg+/0; (b) MCP-1–/–HuBTg+/0. Original magnification ×130.
Figure 4
Figure 4
Cholesterol distribution in the plasma lipoprotein fractions of mice with different genotypes. Plasma samples were pooled from groups of mice with the same genotype (n ≥ 4) and fractionated on an FPLC column. The cholesterol concentration in each fraction was measured with a colorimetric kit. FPLC, fast-protein liquid chromatography; HDL, high-density lipoproteins; IDL, intermediate-density lipoproteins; LDL, low-density lipoproteins; VLDL, very-low-density lipoproteins.

References

    1. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol. 1995;57:791–804. - PubMed
    1. Gerrity RG. The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol. 1981;103:181–190. - PMC - PubMed
    1. Faggiotto A, Ross R, Harker L. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis. 1984;4:323–340. - PubMed
    1. Rollins BJ. Chemokines. Blood. 1997;90:909–928. - PubMed
    1. Cushing SD, et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA. 1990;87:5134–5138. - PMC - PubMed

Publication types